Latest Corporate News News
JPMorgan Chase Reports Q4 Earnings Before Market Open
JPMorgan Chase, the largest US bank, releases fourth-quarter earnings focusing on net interest income, loan volumes, provisions for losses, and investment banking results amid high interest rates. Investors watch for the bank's 2026 economic outlook, which could benchmark financial markets. Strong figures may signal Wall Street resilience despite M&A and IPO declines.
Delta Air Lines Earnings Set Tone for Airline Sector
Delta reports profitability and 2026 revenue outlook before market open, potentially supporting airlines if optimistic on business travel. Cautious views on costs could restrain sector performance. Results come as US earnings season begins, influencing S&P 500 sentiment.
TowneBank Completes $476M Acquisition of Dogwood State Bank
Suffolk-based TowneBank finalized its $476 million purchase of North Carolina's Dogwood State Bank, expanding to 70+ locations across three states with $22B assets. Dogwood operates as a division until November integration; former CEO joins TowneBank leadership. This follows recent acquisitions cementing TowneBank's regional dominance.
Allegiant and Sun Country Airlines Announce Merger
Allegiant Air (ALGT) and Sun Country Airlines (SNCY) revealed a definitive merger on January 11, creating a leading leisure-focused US airline. The deal aims to boost competitiveness in the airline industry. Announced via PRNewswire from Las Vegas and Minneapolis.
Fagron Completes Acquisition of University Compounding Pharmacy
Fagron acquired California-based University Compounding Pharmacy (UCP) for ~$41.5M enterprise value, adding $25M annual revenue in health and wellness compounding. Strengthens US footprint in regulated California market with synergies expected in 18-24 months. Part of 14 recent global acquisitions.
Eisai and Nuvation Bio Sign Exclusive Licensing Deal for Taletrectinib
Eisai entered an exclusive licensing agreement with Nuvation Bio for Taletrectinib in Europe and select countries outside US, China, Japan. The deal expands access to the lung cancer therapy. Announced in Eisai's 2026 news release.
Paramount Advances $30/Share All-Cash Bid for Warner Bros. Discovery
Paramount updates WBD shareholders on pushing its superior $30 per share offer, planning director nominations and bylaw amendments against Netflix deal. Files suit for disclosure to aid informed decisions. Intends to block WBD-Netflix merger dated December 4, 2025.